The Daily Dose from Patient Care Online: October 11, 2022
Your daily dose of clinical news from Patient Care Online.
Weight Loss is Essential to Optimize Type 2 Diabetes Treatment Management
Weight loss of at least 5% to 10% for persons with T2D is realistic and essential, says Nisa Maruthur, MD, MHS, coauthor of the new ADA/EASD consensus report.
Americans Have not Been Truthful about Following COVID-19 Precautions
More than 4 in 10 US adults have either misrepresented their COVID-19 status or failed to adhere to public health measures. A new survey found out why.
Ustekinumab Demonstrates Sustained Clinical, Corticosteroid-free Remission at 4 Years in Adults with Moderate-to-Severe Ulcerative Colitis
Over half of induction responder patients who received ustekinumab at maintenance baseline were in symptomatic remission 4 years later, according to data presented at UEG Week 2022.
ADA/EASD Consensus Report on T2D Management: Coauthor Talks Take-homes for Primary Care
Nisa Maruthur, MD, MHS, a primary care physician and consensus report coauthor, discusses elements of the most effective care for patients with type 2 diabetes (T2D).
Remdesivir for Treatment of Severe COVID-19: Expert Reviews Latest Evidence
Elizabeth Sapey, PhD, discusses findings from the SOLIDARITY study and similar research on the efficacy of remdesivir for treatment of severe disease.
Simple Primary Care Screening Tool Predicts Asthma Diagnosis in Preschoolers
The noninvasive, easily administered tool was able to predict at age 3 years children who would be diagnosed with asthma at age 5 years.
Clinical Practice Guidelines Could be More Primary Care-friendly, says Nisa Maruthur, MD, MHS
Dr Maruthur, a PCP and coauthor for the new ADA/EASD consensus report on T2D, says that's why this report includes the "tips on implementation" sections.
4 New Drugs Approved for Primary Care: Q3 2022
Novel NMDA receptor antagonist approved for the treatment of major depressive disorder, first topical PDE4i approved for plaque psoriasis, and more.
ADA/EASD Calls for Wide Systemic Change to Address Impact of Social Determinants of Health
As long as the role of social determinants of health in T2D is not prioritized, care for these patients will remain poor and outcomes will not improve, says consensus report author.
Are the Southern Hemisphere's High Influenza Rates a Warning for the North This Year?
Influenza rates were higher in Australia during the April-October season this year than they have been in 5 years. Should we be preparing now?
FDA Grants Fast Track Designation to Tirzepatide for Treatment of Obesity, Overweight in Adults
The first-in-class dual incretin receptor agonist was granted fast track designation for investigation in adults with obesity or overweight with weight-related comorbidities.
Candy, Pastries a Gateway to Higher Unhealthy Food Intake among Adolescents, New Study Finds
Findings show that increased consumption of candy among adolescents was linked to a 31% increase in intake of all other ultraprocessed foods.
SGLT-2 Inhibitors, GLP-1 Receptor Agonists not Cost-effective as First-Line T2D Therapy
When modeled as first-line therapy vs metformin, treatment benefit was significantly outweighed by cost for both classes.
Food Insecurity Rose among US Adults with Cardiovascular Disease, According to National Study
The rate of food insecurity among persons with CVD nearly doubled over 20 years, according to new research.
Primary Care Would Benefit from Education on Use of SGLT-2 Inhibitors, GLP-1 Mimetics: Nisa Maruthur, MD, MHS
Dr Maruthur, a primary care physician, helped develop the new ADA/EASD consensus report on T2D management and has suggestions.
Younger Age at Type 2 Diabetes Diagnosis in Adults Increases Risk for Poor Outcomes
A T2D diagnosis in adults aged 50 to 59 years vs 60 to 69 years or ≥70 years was linked to significantly increased risk for cardio- and cerebrovascular disease and all-cause mortality.
WHO Recommends Remdesivir for Severe COVID-19: Expert Perspective on Updated Therapeutic Guideline
Elizabeth Sapey, PhD, discusses the updated recommendations and the research that prompted the decision.
Persistent COVID-19 Vaccine Myths Hamper Immunization for Children
Refractory adult misbeliefs about vaccine safety have increased reluctance to vaccinate US children aged 5-11 years, according to an Annenberg Public Policy center survey.
ADA, EASD 2022 Consensus Report from the Primary Care Point of View, with Nisa Maruthur, MD, MHS
Dr Maruthur, of Johns Hopkins Medicine, talks about how the concept of "holistic" patient care continues to expand in the management of persons with T2D.
